Novel Mitochondria-Based Targeting Restores Responsiveness in Therapeutically Resistant Human Lung Cancer Cells
Liyuan Yin(Cedars-Sinai Medical Center), Leland W.K. Chung(VA Palo Alto Health Care System), Michael Lewis, Yi Zhang(Tianjin Medical University General Hospital), Qinghua Zhou(Sichuan University), Lijuan Yin(Tianjin University of Science and Technology), Yan Ou(Cedars-Sinai Medical Center), Haiyen E. Zhau(Cedars-Sinai Medical Center), Ruoxiang Wang(Cedars-Sinai Medical Center)
Cited by 11
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k